CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
about
Dual effect of oxidative stress on leukemia cancer induction and treatmentRequirement for CDK6 in MLL-rearranged acute myeloid leukemia.G0S2 modulates homeostatic proliferation of naïve CD8⁺ T cells and inhibits oxidative phosphorylation in mitochondriaThe cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.G0S2 inhibits the proliferation of K562 cells by interacting with nucleolin in the cytosol.Palbociclib can overcome mutations in cyclin dependent kinase 6 that break hydrogen bonds between the drug and the protein.Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.Role of the reprogramming factor KLF4 in blood formation.KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis.KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis.Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory NeoplasiaTargeting self-renewal pathways in myeloid malignancies.Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia.Deregulation of the CDX2-KLF4 axis in acute myeloid leukemia and colon cancer.G0S2--a new player in leukemia.Reduction in Cell Viability and in Homeobox Protein Levels Following in Vitro Exposure to δ-tocopherol in Acute Myeloid Leukemia.Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche.DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
P2860
Q26866544-87565191-02BB-40DF-B406-348F14F473B2Q34310186-620947D9-6F96-4E36-9CE8-0E0E75C7F412Q35935293-550D925C-FF42-41AA-B8EE-C286D97A7BBDQ36547690-1DD1EA0F-BF0B-49DB-96B4-DF24EF3CDB35Q37625352-323BD49D-6B14-4FE7-8B18-F0832A0FDCEEQ37723172-C668BA82-30F3-45A0-B23E-C2F0BA041AFEQ38384041-EB4E240D-CF9A-48CB-B58D-9F8D92F19F69Q38747777-EBBC5F16-B643-427A-BC55-D36344E494CBQ38786245-84622058-8E33-4FC6-B2D9-6A4CC68DB89BQ38793918-56494293-0BE8-460F-8647-E8C47A2F2509Q39166310-C066C040-05FB-4D86-99C3-E2D40F5625A5Q39289226-D07F4859-B3C0-46EF-A010-8944A4CF76CCQ40640442-D78118CE-52FB-4F50-9402-77DB3A3375F1Q41104001-DB318042-62F2-4687-9342-023F8EDE156CQ42550846-79E66C0B-923E-4470-A950-0D02631BC5A8Q43090143-51191265-4B0D-48D5-8AAD-4B9AC0B67E99Q43198956-25D57DB7-1A77-45B1-8382-5DBF961032D9Q44432135-9813AD05-81F5-47E8-A3DC-9011E1010D10Q47648907-96CAF529-53A8-4C66-B472-A43273F18C66Q50918212-A22E2A5B-725F-4F2B-8016-BD6AC288E68A
P2860
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@ast
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@en
type
label
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@ast
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@en
prefLabel
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@ast
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@en
P2093
P2860
P356
P1476
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.
@en
P2093
Angela Garding
Christina Miller
Christine Ragu
Christoph Plass
Claudia Scholl
Daniel Mertens
Daniel Walcher
Daniela Martin
Katrin Faber
Lars Bullinger
P2860
P304
P356
10.1172/JCI64745
P407
P577
2012-12-03T00:00:00Z